Canonical: https://ownershiptrace.com/13f/companies/1320

# Who owns Sarepta Therapeutics, Inc. (AVII)? Elite investor 13F holders

5 tracked elite investors reported holding Sarepta Therapeutics, Inc as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Oaktree Capital Management, Bridgewater Associates, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 20151163.00 USD | 1121378.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 15935532.00 USD | 16897000.000000 | Principal | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Oaktree Capital Management](https://ownershiptrace.com/13f/investors/44) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 6344687.00 USD | 6709000.000000 | Principal | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/949509/0000949509-26-000005-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2732662.00 USD | 152068.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | SAREPTA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 44925.00 USD | 2500.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)